Kidney failure: aims for the next 10 years and barriers to success
- PMID: 23727164
- DOI: 10.1016/S0140-6736(13)60438-9
Kidney failure: aims for the next 10 years and barriers to success
Abstract
Although in some parts of the world acute and chronic kidney diseases are preventable or treatable disorders, in many other regions these diseases are left without any care. The nephrology community needs to commit itself to reduction of this divide between high-income and low-income regions. Moreover, new and exciting developments in fields such as pharmacology, genetic, or bioengineering, can give a boost, in the next decade, to a new era of diagnosis and treatment of kidney diseases, which should be made available to more patients.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Acute Kidney Injury in Poor Countries Should No Longer Be a Death Sentence: The ISN '0 by 25' Project.Ann Nutr Metab. 2015;66 Suppl 3:42-4. doi: 10.1159/000381246. Epub 2015 Jun 18. Ann Nutr Metab. 2015. PMID: 26088047
-
[Progress in clinical nephrology 2008: CKD, and AKI as well].Nihon Jinzo Gakkai Shi. 2009;51(1):13-8. Nihon Jinzo Gakkai Shi. 2009. PMID: 19238902 Review. Japanese. No abstract available.
-
[Hemodialysis in the treatment of acute and chronic renal failure in children].Pediatriia. 1977 Feb;(2):52-6. Pediatriia. 1977. PMID: 865981 Russian. No abstract available.
-
[Activity in a nephrology ward in 2009, Piemonte, Italy].G Ital Nefrol. 2011 Nov-Dec;28(6):654-60. G Ital Nefrol. 2011. PMID: 22167617 Italian.
-
[Problems of vacular accesses in patients that start on HD in Spain. Analysis of the current situation and its consequences: proposal for solutions].Nefrologia. 2006;26 Suppl 3:46-51. Nefrologia. 2006. PMID: 17469427 Review. Spanish. No abstract available.
Cited by
-
Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism.Front Immunol. 2023 Sep 19;14:1209464. doi: 10.3389/fimmu.2023.1209464. eCollection 2023. Front Immunol. 2023. PMID: 37795100 Free PMC article.
-
Potential Surrogate Outcomes for Kidney Failure in Advanced CKD: Evaluation of Power and Predictive Ability in CKDopps.Kidney Med. 2021 Dec 11;4(2):100395. doi: 10.1016/j.xkme.2021.10.008. eCollection 2022 Feb. Kidney Med. 2021. PMID: 35243307 Free PMC article.
-
Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy.Front Immunol. 2022 Feb 4;13:821681. doi: 10.3389/fimmu.2022.821681. eCollection 2022. Front Immunol. 2022. PMID: 35185912 Free PMC article.
-
Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling.Front Immunol. 2021 Nov 11;12:774052. doi: 10.3389/fimmu.2021.774052. eCollection 2021. Front Immunol. 2021. PMID: 34858433 Free PMC article.
-
Neighborhood Socioeconomic Status and Identification of Patients With CKD Using Electronic Health Records.Am J Kidney Dis. 2021 Jul;78(1):57-65.e1. doi: 10.1053/j.ajkd.2020.10.019. Epub 2020 Dec 22. Am J Kidney Dis. 2021. PMID: 33359151 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
